Success Stories: Postdoctoral Associate from China Secures EB-1A Approval Without RFE

Posted by wegreened on January 30, 2026 in Biology (Pathology and Immunology, Human Genetics, Genomics, Molecular Biology, Animal, Plant, Microbiology, Genetics, Botany), EB1 Green Card

Client’s Testimonial:

“Thanks for your email! It is great news.”

On October 24^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Associate in the Field of Genetics (Approval Notice).

General Field: Genetics

Position at the Time of Case Filing: Postdoctoral Associate

Country of Origin: China

State of Residence at the Time of Filing: California

Approval Notice Date: October 24^th, 2025

Processing Time: 10 months 19 days

Case Summary:

“These insights advance clinical efforts in reproductive health, supporting precision medicine and improving fertilization rates. This, in turn, reduces the cost of care and contributes to economic stability. Therefore, [Client]’s outstanding contributions to his field render him a highly sought-after researcher in the US.”

This powerful endorsement comes from one of six recommendation letters from experts who supported our client’s EB-1A (Alien of Extraordinary Ability) petition. The client, a native of China who holds a Ph.D. in genetics, is currently a postdoctoral associate in the field. With our assistance, the petition was approved in approximately 10 months without an RFE.

Research of Extraordinary Significance: In preparing the petition, North America Immigration Law Group (NAILG) emphasized that the client’s research addresses one of the most critical questions in molecular genetics—how genomes defend themselves against transposons and maintain stability across generations. The client’s work has illuminated the molecular basis of piRNA (Piwi-interacting RNA) pathways, a small RNA system essential for silencing transposable elements and preventing genomic instability that can cause infertility and genetic disorders.

To demonstrate the client’s sustained acclaim in the field, we presented the following evidence:

Authored 13 peer-reviewed journal articles (2 first-authored and 2 co-first-authored), 3 abstracts, and 1 preprint.
Research has been cited 1,396 times.
Conducted at least 28 peer reviews for highly distinguished journals.
Research supported by prestigious organizations, including the National Institutes of Health (NIH), Ministry of Science and Technology of the People’s Republic of China (MOST), Ellison Medical Foundation, Starr Foundation, Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Institutes of Health Research (CIHR), and National Research Foundation of Korea (NRF).

EB1A Approval and Outlook:

This success demonstrates NAILG’s commitment to representing world-class scientists whose research not only advances knowledge but also strengthens the United States’ leadership in biomedical innovation. The client’s continuing research in small RNA and genetic regulation promises to expand understanding of genome defense mechanisms and open new pathways for genomic medicine, reproductive health, and RNA-based therapies—a future that will undoubtedly benefit science and society alike.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%